Diabetes;Diabète

Medecine et Hygiene

Volumn 56, Issue 2191, 1998, Pages 21-28

  Gerber, P ^a  

^a Centro di Diabetologia   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006501897     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes. Diabetes Care 1997; 20: 1183-97.
2. National Health and Nutrition Examination Survey. Diabetes Care 1990; 12: 464-74.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in the insulin-dependent diabetes mellitus. N Eng J Med 1993; 329: 977-86.
4. Ebeling P, Jansson PA, Smith U, Lalli C, Bolli GB, Koivisto VA. Strategies toward improved control during insulin lispro therapy in IDDM. Diabetes Care 1997; 20: 1287-9.
5. Fleming DR, Jacober SJ, Vandenberg MA, et al. The safety of injecting insulin through clothing. J Clin Applied Res Educ 1997; 20: 244.
6. Holleman F, Schmitt H, Rottiers K, Rees A, Symanowski S, Anderson JH, The Benelux UK insulin Lispro Study Group. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. Diabetes Care 1997; 20: 1827-32.
7. Bott S, Bott U, Berger M, Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997; 40: 926-32.
8. Bolinder J, Hagström-Toft E, Ungerstedt U, Arner P. Self-monitoring of blood glucose in type I diabetic patients: Comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997; 20: 64-70.
9. Gerber P, Diabète. Méd et Hyg 1997; 55: 25-32.
10. Ikova H, Glaser B, Tunckale A, Bagriçik N, Ceraso E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 1997; 20: 1353-6.
11. Caixas A, Ordonez-Llanos J, De Leiva A, Payés A, Homs R, Perez A. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 1997; 446: 1207-13.
12. Haffner SM. The Scandinavian Simvastatin Survival Study (4S). Sub-group analysis of diabetic subjects: Implications for the prevention of coronary heart disease. Diabetes Care 1997; 20: 469-71.
13. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin of coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
14. Gilmer TD, O'Connor. The Cost Health Plans of Poor Glycemic Control. Diabetes Care 1997; 20: 1847-53.
15. Batstra MR, Pinta M, Quan J, Mudler P, De Beaufort CE, Bruining GJ, Aanstoot HJ. Fluctuations in GAD 65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care 1997; 20: 642-9.
16. Lohmann T, Seissler J, Verlohren HJ, et al. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 1997; 20: 524-9.
17. Turner R, Stratton I, Horton V, et al., for UK Prospective Diabetes Study (UKPDS) Goup. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 1997; 350: 1288-93.
18. Haffner SM, Miettinen H, Stern MP. Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 1997; 40: 62-6.
19. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperiinsulinemia is a predictor of increased body weight gain and obesity in Pima indian children. Diabetes 1997; 46: 1341-5.
20. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM. Diabetes 1997; 46: 701-10.
21. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-44.